• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 对代谢的控制——癌症及其他。

Control of metabolism by p53 - Cancer and beyond.

机构信息

The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

出版信息

Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):32-42. doi: 10.1016/j.bbcan.2018.06.001. Epub 2018 Jun 5.

DOI:10.1016/j.bbcan.2018.06.001
PMID:29883595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6102416/
Abstract

p53 is an important tumour suppressor gene, with loss of p53 contributing to the development of most human cancers. However, the activation of p53 in response to stress signals underpins a role for p53 in diverse aspects of health and disease. Activities of p53 that regulate metabolism can play a role in maintaining homeostasis and protecting cells from damage - so preventing disease development. By contrast, either loss or over-activation of p53 can contribute to numerous metabolic pathologies, including aging, obesity and diabetes.

摘要

p53 是一种重要的肿瘤抑制基因,p53 的缺失导致了大多数人类癌症的发生。然而,p53 在应激信号下的激活为其在健康和疾病的多个方面发挥作用奠定了基础。p53 调节代谢的活性可以在维持体内平衡和保护细胞免受损伤方面发挥作用,从而预防疾病的发生。相比之下,p53 的缺失或过度激活均可导致多种代谢疾病,包括衰老、肥胖和糖尿病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/e82ca675cb76/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/bc494d3a395d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/c5a1f78bdf91/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/e82ca675cb76/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/bc494d3a395d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/c5a1f78bdf91/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/484b/6102416/e82ca675cb76/gr3.jpg

相似文献

1
Control of metabolism by p53 - Cancer and beyond.p53 对代谢的控制——癌症及其他。
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):32-42. doi: 10.1016/j.bbcan.2018.06.001. Epub 2018 Jun 5.
2
Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer.肿瘤抑制因子 p53 的代谢功能:在正常生理学、代谢紊乱和癌症中的意义。
Mol Metab. 2020 Mar;33:2-22. doi: 10.1016/j.molmet.2019.10.002. Epub 2019 Oct 18.
3
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.Sirtuin1-p53 调节轴在衰老、癌症和细胞重编程中的作用。
Ageing Res Rev. 2018 May;43:64-80. doi: 10.1016/j.arr.2018.02.004. Epub 2018 Feb 21.
4
p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells.p53 诱导的 DPYSL4 与线粒体超级复合物相关联,并调节脂肪细胞和癌细胞中的能量代谢。
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8370-8375. doi: 10.1073/pnas.1804243115. Epub 2018 Jul 30.
5
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.端粒下游p53对细胞衰老、组织功能及癌症的调控
Cold Spring Harb Perspect Med. 2017 May 1;7(5):a026088. doi: 10.1101/cshperspect.a026088.
6
Unravelling mechanisms of p53-mediated tumour suppression.揭示 p53 介导的肿瘤抑制机制。
Nat Rev Cancer. 2014 May;14(5):359-70. doi: 10.1038/nrc3711. Epub 2014 Apr 17.
7
The role of the p53 tumor suppressor in metabolism and diabetes.p53肿瘤抑制因子在代谢和糖尿病中的作用。
J Endocrinol. 2016 Nov;231(2):R61-R75. doi: 10.1530/JOE-16-0324. Epub 2016 Sep 9.
8
The Dysfunctional MDM2-p53 Axis in Adipocytes Contributes to Aging-Related Metabolic Complications by Induction of Lipodystrophy.脂肪细胞中功能失调的 MDM2-p53 轴通过诱导脂肪营养不良导致与衰老相关的代谢并发症。
Diabetes. 2018 Nov;67(11):2397-2409. doi: 10.2337/db18-0684. Epub 2018 Aug 21.
9
P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds.P53:一种在多种细胞过程中起关键作用的蛋白质,包括核应激和核糖体生物发生,突出了潜在的治疗化合物。
Biochem Pharmacol. 2024 Aug;226:116332. doi: 10.1016/j.bcp.2024.116332. Epub 2024 Jun 1.
10
The Intricate Role of p53 in Adipocyte Differentiation and Function.p53 在脂肪细胞分化和功能中的复杂作用。
Cells. 2020 Dec 7;9(12):2621. doi: 10.3390/cells9122621.

引用本文的文献

1
PUMA reduces FASN ubiquitination to promote lipid accumulation and tumor progression in human clear cell renal cell carcinoma.在人肾透明细胞癌中,PUMA通过减少脂肪酸合酶(FASN)的泛素化来促进脂质积累和肿瘤进展。
Cell Death Dis. 2025 Jun 19;16(1):460. doi: 10.1038/s41419-025-07782-y.
2
Targeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential.靶向p53-p21信号通路以增强间充质干细胞的再生潜能。
Regen Ther. 2025 Apr 7;29:352-363. doi: 10.1016/j.reth.2025.03.007. eCollection 2025 Jun.
3
Unleashing the Potential of Metal Ions in cGAS-STING Activation: Advancing Nanomaterial-Based Tumor Immunotherapy.

本文引用的文献

1
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis.p53肿瘤抑制因子在代谢与铁死亡调控中的作用
Front Endocrinol (Lausanne). 2018 Apr 11;9:124. doi: 10.3389/fendo.2018.00124. eCollection 2018.
2
Emerging Roles of p53 Family Members in Glucose Metabolism.p53 家族成员在葡萄糖代谢中的新兴作用。
Int J Mol Sci. 2018 Mar 8;19(3):776. doi: 10.3390/ijms19030776.
3
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α.突变型 p53 通过调控 PGC-1α 来控制肿瘤代谢和转移。
释放金属离子在cGAS-STING激活中的潜力:推进基于纳米材料的肿瘤免疫治疗
ACS Omega. 2025 Mar 17;10(12):11723-11742. doi: 10.1021/acsomega.4c10865. eCollection 2025 Apr 1.
4
Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: and anticancer activities and newly discovered effects on cancer metabolic pathways.用于乳腺癌实验性治疗的MDM2和NFAT1双重抑制剂:抗癌活性及对癌症代谢途径的新发现作用
Front Pharmacol. 2025 Feb 19;16:1531667. doi: 10.3389/fphar.2025.1531667. eCollection 2025.
5
Harnessing p53 for targeted cancer therapy: new advances and future directions.利用p53进行靶向癌症治疗:新进展与未来方向。
Transcription. 2025 Feb;16(1):3-46. doi: 10.1080/21541264.2025.2452711. Epub 2025 Mar 3.
6
Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics.调控环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白信号轴:推进骨肉瘤治疗的创新策略
Front Immunol. 2025 Feb 7;16:1539396. doi: 10.3389/fimmu.2025.1539396. eCollection 2025.
7
Respiratory complex I-mediated NAD regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21 expression by SIRT3 and SIRT7.呼吸链复合体I介导的NAD再生通过SIRT3和SIRT7对p21表达的转录和翻译控制来调节癌细胞增殖。
Mol Oncol. 2025 Jun;19(6):1775-1796. doi: 10.1002/1878-0261.13808. Epub 2025 Jan 28.
8
Targeting APE1: Advancements in the Diagnosis and Treatment of Tumors.靶向 APE1:肿瘤诊断与治疗的进展
Protein Pept Lett. 2025;32(1):18-33. doi: 10.2174/0109298665338519241114103223.
9
Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer.真核起始因子 2 激酶 GCN2 与 p53 信号通路的协调作用支持嘌呤代谢和前列腺癌的进展。
Sci Signal. 2024 Nov 26;17(864):eadp1375. doi: 10.1126/scisignal.adp1375.
10
Understanding serine and glycine metabolism in cancer: a path towards precision medicine to improve patient's outcomes.了解癌症中的丝氨酸和甘氨酸代谢:通向精准医学以改善患者预后的途径。
Discov Oncol. 2024 Nov 13;15(1):652. doi: 10.1007/s12672-024-01544-6.
Genes Dev. 2018 Feb 1;32(3-4):230-243. doi: 10.1101/gad.309062.117. Epub 2018 Feb 20.
4
p53 isoforms regulate premature aging in human cells.p53 异构体调节人细胞的早衰。
Oncogene. 2018 May;37(18):2379-2393. doi: 10.1038/s41388-017-0101-3. Epub 2018 Feb 12.
5
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.p53 抑制癌细胞代谢应激诱导的铁死亡。
Cell Rep. 2018 Jan 16;22(3):569-575. doi: 10.1016/j.celrep.2017.12.077.
6
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis.低剂量多柔比星对 p53 的药理学刺激可改善饮食诱导的非酒精性脂肪性肝病和脂肪性肝炎。
Mol Metab. 2018 Feb;8:132-143. doi: 10.1016/j.molmet.2017.12.005. Epub 2017 Dec 15.
7
P53 at the start of the 21st century: lessons from elephants.21世纪初的p53:来自大象的启示。
F1000Res. 2017 Nov 22;6:2041. doi: 10.12688/f1000research.12682.1. eCollection 2017.
8
Deciphering p53 signaling in tumor suppression.解析肿瘤抑制中的 p53 信号通路。
Curr Opin Cell Biol. 2018 Apr;51:65-72. doi: 10.1016/j.ceb.2017.11.005. Epub 2017 Nov 28.
9
Relevance of the p53-MDM2 axis to aging.p53-MDM2 轴与衰老的相关性。
Cell Death Differ. 2018 Jan;25(1):169-179. doi: 10.1038/cdd.2017.187. Epub 2017 Dec 1.
10
p53 promotes AKT and SP1-dependent metabolism through the pentose phosphate pathway that inhibits apoptosis in response to Nutlin-3a.p53 通过戊糖磷酸途径促进 AKT 和 SP1 依赖性代谢,从而抑制 Nutlin-3a 诱导的细胞凋亡。
J Mol Cell Biol. 2018 Aug 1;10(4):331-340. doi: 10.1093/jmcb/mjx051.